GLP-1 medications carry a boxed warning that has made many patients uneasy, but the warning is often misunderstood
To our knowledge, no study assessed the potential of abuse of these medications anecdotally reported in anorexia or bulimia nervosa, which would require further investigation
Explore our co-located event, the Biosimilars & Innovator Biologics Summit, for more key developments
Among them are Henrys available medications, which put the company in a specific place compared to direct competitors
But the weight loss injectables landscape now includes several options: liraglutide (Saxenda, an older daily GLP-1), semaglutide (Ozempic/Wegovy, weekly), and tirzepatide (Mounjaro/Zepbound, weekly dual-agonist)